WO2012145555A3 - Procédé de production de substances comprenant un gaz sursaturé, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci - Google Patents

Procédé de production de substances comprenant un gaz sursaturé, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci Download PDF

Info

Publication number
WO2012145555A3
WO2012145555A3 PCT/US2012/034316 US2012034316W WO2012145555A3 WO 2012145555 A3 WO2012145555 A3 WO 2012145555A3 US 2012034316 W US2012034316 W US 2012034316W WO 2012145555 A3 WO2012145555 A3 WO 2012145555A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery device
methods
transdermal delivery
delivery devices
producing substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/034316
Other languages
English (en)
Other versions
WO2012145555A2 (fr
Inventor
Norbert Kiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INVISIDERM LLC
Original Assignee
INVISIDERM LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/033060 external-priority patent/WO2012144990A1/fr
Priority to AU2012245373A priority Critical patent/AU2012245373A1/en
Priority to JP2014506557A priority patent/JP2014515666A/ja
Priority to KR1020137030605A priority patent/KR20140035378A/ko
Priority to CA2833851A priority patent/CA2833851A1/fr
Priority to RU2013151160/14A priority patent/RU2013151160A/ru
Priority to BR112013027006A priority patent/BR112013027006A2/pt
Priority to CN201280030260.2A priority patent/CN103648576A/zh
Priority to MX2013012205A priority patent/MX2013012205A/es
Application filed by INVISIDERM LLC filed Critical INVISIDERM LLC
Priority to US14/112,896 priority patent/US10130800B2/en
Priority to EP12774807.7A priority patent/EP2699306A4/fr
Priority to SG2013077706A priority patent/SG194215A1/en
Publication of WO2012145555A2 publication Critical patent/WO2012145555A2/fr
Publication of WO2012145555A3 publication Critical patent/WO2012145555A3/fr
Anticipated expiration legal-status Critical
Priority to IL228970A priority patent/IL228970A0/en
Priority to ZA2013/07980A priority patent/ZA201307980B/en
Priority to US16/193,832 priority patent/US20190091454A1/en
Priority to US17/412,063 priority patent/US12390626B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8218—Gas operated
    • A61M2205/8225—Gas operated using incorporated gas cartridges for the driving gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/30—Gas therapy for therapeutic treatment of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un dispositif d'administration transdermique non invasive généralement associé à un appareil mécanique portatif d'administration transdermique non invasive d'un gaz, d'agents pharmaceutiques petits ou grands solubles dans l'eau (hydrophiles), de vitamines, ou d'autres agents thérapeutiques. Elle concerne également des composants de ces dispositifs d'administration, des procédés de production d'une substance comprenant une quantité sursaturée d'un gaz dissous, ainsi que des méthodes d'administration d'un agent thérapeutique ou de traitement d'une maladie ou d'une affection au moyen des dispositifs d'administration de l'invention.
PCT/US2012/034316 2011-04-19 2012-04-19 Procédé de production de substances comprenant un gaz sursaturé, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci Ceased WO2012145555A2 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
EP12774807.7A EP2699306A4 (fr) 2011-04-19 2012-04-19 Procédé de production de substances comprenant un gaz sursaturé, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci
JP2014506557A JP2014515666A (ja) 2011-04-19 2012-04-19 過飽和気体を伴う物質を生成する方法、その経皮デリバリーデバイス、および、その使用
KR1020137030605A KR20140035378A (ko) 2011-04-19 2012-04-19 과포화 가스를 갖는 물질의 제조，그 경피적 전달 기기 및 그 사용 방법
CA2833851A CA2833851A1 (fr) 2011-04-19 2012-04-19 Procede de production de substances comprenant un gaz sursature, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci
RU2013151160/14A RU2013151160A (ru) 2011-04-19 2012-04-19 Способ создания веществ, перенасыщенных газом, устройство трансдермальной доставки и его использование
BR112013027006A BR112013027006A2 (pt) 2011-04-19 2012-04-19 método de produzir substâncias com gás supersaturado, dispositivo de distribuição transdérmica do mesmo
CN201280030260.2A CN103648576A (zh) 2011-04-19 2012-04-19 含过饱和气体物质的生产方法及其透皮给药设备与使用
MX2013012205A MX2013012205A (es) 2011-04-19 2012-04-19 Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.
US14/112,896 US10130800B2 (en) 2012-01-27 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
AU2012245373A AU2012245373A1 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
SG2013077706A SG194215A1 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
IL228970A IL228970A0 (en) 2011-04-19 2013-10-20 A method to create materials with a super-saturation of gas, a device for introducing them through the skin, and their uses
ZA2013/07980A ZA201307980B (en) 2011-04-19 2013-10-24 Method of producing substances with supersaturated gas,transdermal delivery device thereof and uses thereof
US16/193,832 US20190091454A1 (en) 2012-01-27 2018-11-16 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
US17/412,063 US12390626B2 (en) 2012-01-27 2021-08-25 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
USPCT/US2011/033060 2011-04-19
PCT/US2011/033060 WO2012144990A1 (fr) 2011-04-19 2011-04-19 Procédé de fabrication de substances avec du gaz sursaturé, administration par voie transdermique de celles-ci, et utilisation de celles-ci
US201261591443P 2012-01-27 2012-01-27
US61/591,443 2012-01-27

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/112,896 A-371-Of-International US10130800B2 (en) 2012-01-27 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
US16/193,832 Continuation US20190091454A1 (en) 2012-01-27 2018-11-16 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof

Publications (2)

Publication Number Publication Date
WO2012145555A2 WO2012145555A2 (fr) 2012-10-26
WO2012145555A3 true WO2012145555A3 (fr) 2013-01-17

Family

ID=47042166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/034316 Ceased WO2012145555A2 (fr) 2011-04-19 2012-04-19 Procédé de production de substances comprenant un gaz sursaturé, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci

Country Status (13)

Country Link
EP (1) EP2699306A4 (fr)
JP (1) JP2014515666A (fr)
KR (1) KR20140035378A (fr)
CN (1) CN103648576A (fr)
AU (1) AU2012245373A1 (fr)
BR (1) BR112013027006A2 (fr)
CA (1) CA2833851A1 (fr)
IL (1) IL228970A0 (fr)
MX (1) MX2013012205A (fr)
RU (1) RU2013151160A (fr)
SG (1) SG194215A1 (fr)
WO (1) WO2012145555A2 (fr)
ZA (1) ZA201307980B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130800B2 (en) 2012-01-27 2018-11-20 Invisiderm, Llc Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
CN115154882A (zh) * 2014-03-26 2022-10-11 纳诺麦德皮肤护理公司 物质传送装置及头部
WO2017136087A1 (fr) * 2016-02-05 2017-08-10 Clover Hill Heal Thealthcare, Inc. Dispositif d'administration de traitement nasal comprenant du dioxyde de carbone et une solution saline, et méthodes, comprenant de faibles débits

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851544A (en) * 1997-12-18 1998-12-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
US20020040205A1 (en) * 2000-02-28 2002-04-04 Rasor Ned S. Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
US20040087916A1 (en) * 2001-09-28 2004-05-06 Pickup Ray L. Cutaneous administration system
US20080058709A1 (en) * 2006-08-31 2008-03-06 Da Silva Freitas Mario A Method and apparatus that associate the parenteral injection of medical grade carbon dioxide (co2) concomitantly with the application of infrared radiation from thermal and/or light sources using control by means of cutaneous and/or body thermometry

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20221228U1 (de) * 2002-11-12 2005-07-07 Bode, Lothar Druckinjektions-Handgerät zum Einbringen von Substanzen unter Druck eines gasförmigen oder flüssigen Druckmittels in eine zu behandelnde Hautstelle
US7857167B1 (en) * 2005-08-29 2010-12-28 Anthony Scott Hollars Compressed gas cartridge permeation dispenser having a predictable permeation rate
US9713570B2 (en) * 2008-04-09 2017-07-25 Respiderm Corporation Mobile apparatus for the dispersion and transdermal delivery of pharmaceutical, medical or purified carbon dioxide gas
CN101917954A (zh) * 2008-12-26 2010-12-15 中村正一 二氧化碳气雾压浴系统
US8118777B2 (en) * 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
WO2011007425A1 (fr) * 2009-07-14 2011-01-20 有限会社アミューズカンパニー Dispositif assurant une absorption percutanée de gaz carbonique, procédé d'absorption percutanée de gaz carbonique et enveloppe

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851544A (en) * 1997-12-18 1998-12-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
US20020040205A1 (en) * 2000-02-28 2002-04-04 Rasor Ned S. Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
US20040087916A1 (en) * 2001-09-28 2004-05-06 Pickup Ray L. Cutaneous administration system
US20080058709A1 (en) * 2006-08-31 2008-03-06 Da Silva Freitas Mario A Method and apparatus that associate the parenteral injection of medical grade carbon dioxide (co2) concomitantly with the application of infrared radiation from thermal and/or light sources using control by means of cutaneous and/or body thermometry

Also Published As

Publication number Publication date
CA2833851A1 (fr) 2012-10-26
JP2014515666A (ja) 2014-07-03
IL228970A0 (en) 2013-12-31
EP2699306A4 (fr) 2016-07-27
SG194215A1 (en) 2013-11-29
KR20140035378A (ko) 2014-03-21
RU2013151160A (ru) 2015-05-27
BR112013027006A2 (pt) 2016-12-27
AU2012245373A1 (en) 2013-11-14
CN103648576A (zh) 2014-03-19
MX2013012205A (es) 2014-05-28
ZA201307980B (en) 2014-06-25
WO2012145555A2 (fr) 2012-10-26
EP2699306A2 (fr) 2014-02-26

Similar Documents

Publication Publication Date Title
MX2013012206A (es) Metodo para producir substancias con gas sobresaturado,dispositivo de suministro transdermico de las mismas, y usos de las mismas.
WO2008131056A3 (fr) Préparations monoeximiques a libération soutenue d'analgésiques opioïdes et non opioïdes
WO2011112229A3 (fr) Préparations d'agent thérapeutique pour une administration dans une lumière du tractus intestinal à l'aide d'un dispositif d'administration de médicament avalable
WO2008131057A3 (fr) Préparations à libération contrôlée d'analgésiques opioïdes et non opioïdes
WO2011163594A3 (fr) Promédicaments de composés nh-acides : dérivés esters, carbonates, carbamates et phosphonates
WO2011140274A3 (fr) Méthode et dispositif permettant l'administration transdermique d'hormone parathyroïdienne au moyen d'un réseau de microprojections
WO2009065406A3 (fr) Nouveaux composés hydrocarbonés cycliques pour le traitement de maladies
MX2014004548A (es) Metodos para tratar pacientes pediatricos usando dexmedetomidina.
WO2013101897A3 (fr) Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
WO2007117509A3 (fr) Vitesses d'administration élevées pour préparations médicamenteuses lipidiques et méthodes de traitement associées
WO2013138702A3 (fr) Méthodes de prévision des événements indésirables gastro-intestinaux immunitaires chez les patients traités par modulation de la voie de co‑stimulation
MX365688B (es) Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino.
WO2014036556A3 (fr) Systèmes d'administration de médicaments et méthodes de traitement du cancer de la prostate
WO2008025790A3 (fr) Utilisation de formulations opioïdes dans des dispositifs d'administration de médicaments dans aiguille
WO2011151722A3 (fr) Méthodes et compositions de traitement pharmaceutique par voie orale
MY157187A (en) Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2013138628A3 (fr) Préparation injectable à l'ibuprofène
WO2014160216A3 (fr) Agents anticancéreux à double ciblage
CO7101247A2 (es) Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas
WO2016100949A3 (fr) Procédé et compositions permettant de dissoudre ou de solubiliser des agents thérapeutiques
EP4578461A3 (fr) Méthodes de traitement de la maladie de parkinson par administration d'apomorphine à une muqueuse buccale
EP3970729A3 (fr) Procédés d'administration de concentrations élevées d'oxyde nitrique
PH12015500653B1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
WO2012145554A3 (fr) Procédé de production de substances comprenant un gaz sursaturé, dispositif d'administration transdermique de ces substances, et utilisations de celles-ci
WO2008051527A3 (fr) Libération prolongée d'agents pour la gestion d'une douleur localisée

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12774807

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2014506557

Country of ref document: JP

Kind code of ref document: A

Ref document number: 2833851

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 14112896

Country of ref document: US

Ref document number: MX/A/2013/012205

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2012245373

Country of ref document: AU

Date of ref document: 20120419

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2012774807

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2013151160

Country of ref document: RU

Kind code of ref document: A

Ref document number: 20137030605

Country of ref document: KR

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013027006

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013027006

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20131018